# DESCRIPTION

## FIELD OF THE INVENTION

- relate to microfluidic isolation of extracellular vesicles

## BACKGROUND

- introduce extracellular vesicles
- describe types of extracellular vesicles
- discuss tumorigenesis and extracellular vesicles

## SUMMARY

- introduce microfluidic system for isolating target EVs
- describe high specificity and short time period
- introduce microfluidic device with channels and binding moieties
- describe herringbone grooves and antibody immobilization
- discuss target EV release for downstream characterization
- introduce surface immobilization techniques
- describe elongated linker molecules and capture efficiency
- introduce microfluidic device with grooves or ridges
- describe elongate flexible linker molecules and binding moieties
- introduce optional features, including gelatin layers
- describe binding of gelatin to internal surface
- introduce subsequent layers of gelatin
- describe indirect binding of elongate flexible linkers
- introduce nanostructures and binding moieties
- describe indirect binding of elongate flexible linkers to nanostructures
- introduce multiple layers of gelatin and nanostructures
- describe elongate flexible linker molecules, including PEG and dextran
- introduce binding moieties, including antibodies and aptamers
- describe specific binding to target extracellular vesicles
- introduce V-shaped grooves and chaotic mixing
- describe method of capturing target extracellular vesicles
- introduce substrate with attached elongate flexible linker molecules
- describe flowing fluid sample through channel
- introduce optional features, including microfluidic channel and gelatin layers
- describe releasing bound target extracellular vesicles
- introduce method of capturing target extracellular vesicles with depletion module
- describe flowing fluid sample through depletion module
- introduce capture module with microfluidic channel and elongate flexible linker molecules
- describe capturing target extracellular vesicles
- introduce isolating biological cargo from extracellular vesicles
- describe analyzing biological cargo
- introduce depletion module with microfluidic channel
- describe capturing non-target extracellular vesicles
- discuss advantages over prior technologies
- discuss specificity and throughput of systems
- discuss release of captured target extracellular vesicles

## DETAILED DESCRIPTION

- introduce microfluidic systems for isolating and capturing target EVs
- describe functionalized microfluidic device with herringbone grooves
- motivate clinical potential of microfluidic systems
- overview of target EV capture and analysis
- introduce extracellular vesicles (EVs) and their role in intercellular communication
- discuss EVs as biomarkers for various pathological conditions
- motivate need for specific target EV isolation techniques
- describe different types of target EVs and their clinical applications
- overview of systems and methods for isolating and capturing target EVs
- introduce microfluidic devices with herringbone grooves for chaotic mixing
- describe depletion module for removing non-target EVs
- introduce capture module for capturing target EVs
- describe microfluidic device with antibody-coated surfaces
- illustrate microfluidic system with depletion and capture modules
- describe microfluidic device with herringbone patterns for chaotic mixing
- motivate use of herringbone patterns for increasing surface area
- describe depletion module for removing non-specific EVs
- introduce binding moieties for removing non-target EVs
- describe microfluidic device as a cartridge for processing liquid samples
- illustrate microfluidic device with inlets, channels, and outlets
- describe herringbone patterns in microfluidic channels
- motivate use of offset column design for promoting mixing
- describe forming of interspersed grooves for promoting transverse movement
- overview of downstream processing techniques for analyzing captured EVs
- describe RNA sequencing analysis on captured EVs
- motivate use of microfluidic systems for clinical investigation
- conclude with experimental results of exemplary implementations
- describe depletion device
- describe flow control device
- describe analyzer device
- introduce microfluidic device
- describe herringbone pattern grooves
- explain microvortices generation
- discuss groove heights
- discuss channel dimensions
- describe particle capture efficiency
- introduce soft lithography techniques
- describe channel cross-section
- discuss groove formation
- introduce surface chemistry
- describe surface chemistry 200A
- describe surface chemistry 200B
- describe surface chemistry 200C
- discuss flexible linker molecules
- describe branched linkers
- discuss gelatin layers
- describe nanostructures
- discuss binding moieties
- describe EV capture experiment
- discuss EV capture results
- introduce release mechanisms
- describe particle capture efficiency calculation
- discuss microfluidic device manufacturing
- describe channel treatment
- discuss particle capture efficiency improvement
- describe surface chemistry application
- discuss target EV capture

### III. Methods for Isolating and Capturing Target EVs

- fabricate microfluidic device
- select materials for substrates
- describe PDMS and glass fabrication
- discuss 3D printing techniques
- scale up microfluidic device fabrication
- introduce gelatin functionalization
- describe layer-by-layer process
- form gelatin layers on substrate
- wash excess gelatin solution
- form subsequent gelatin layers
- solidify gelatin layers
- contact with nanostructures
- introduce microfluidic surface modification
- describe silane-based chemistry
- immobilize capture antibodies
- use LBL technique for biotin-gelatin layers
- characterize nanocoating thickness
- introduce streptavidin-coated nanoparticles
- immobilize antibodies onto channel surface
- discuss antibody conjugation with linker molecules
- describe cell culture
- generate GBM20/3 and Gli36 cell lines
- culture cells in DMEM with FBS and P/S
- passage cells using trypsin/EDTA
- produce fluorescently labeled EVs
- isolate EVs by ultracentrifugation
- quantify EVs using TRPS qNano instrument
- release captured EVs using proteinase K or temperature gradient
- isolate EVs with magnetic beads
- conjugate magnetic beads with biotinylated Cetuximab
- pull down captured EVs using magnetic force

### IV. Downstream Processing Techniques for Analyzing Captured Target EVs

- capture target EVs using bioresponsive nanostructures
- release target EVs using temperature or localized shear stress
- image captured EVs using confocal microscopy
- extract RNA from captured EVs
- perform quantitative RT-PCR
- perform digital PCR
- prepare library for RNA sequencing
- sequence RNA using HiSeq2000
- analyze RNA sequencing data
- perform quality control using FASTQC
- align RNA sequencing data to reference genome
- quantify read counts per gene
- perform hierarchical clustering of samples
- perform differential expression analysis
- plot heat maps using gplots package in R

## EXAMPLES

- describe examples of the invention

### Example 1

- select antibodies based on surface markers
- conduct experiments using microfluidic devices with different antibodies
- identify most promising tumor-specific antibody candidates
- engineer cells to produce fluorescently labeled EVs
- spike fluorescent EVs into human plasma or serum
- process samples through microfluidic devices
- visualize captured EVs by confocal microscopy
- test specificity of antibody capture
- analyze binding of mixed population of EVs to different antibodies
- compare capturing two fluorescently labeled EVs on microfluidic devices
- compute enrichment ratio metric
- evaluate effect of antibody dilution on tumor-derived EV capture
- compare capture efficiencies of EVs derived from GBM cell lines
- quantify tumor-specific message at different dilution ratios

### Example 2

- evaluate impact of processing conditions on EV isolation
- quantify effect of flow rate on EV capture
- compute enrichment ratio metric
- compare microfluidic device performance to bulk EV analysis

### Example 3

- evaluate effect of linker molecule length on capture efficiency
- measure Z-potential as indication of specific binding
- identify optimal linker molecule length
- show decrease in capture efficiency with increasing linker molecule length

### Example 4

- characterize captured nanoparticle distribution across surfaces of microfluidic devices

### Example 5

- investigate ways to increase specific capture of tumor-derived EVs
- run liquid samples through depletion chip before functionalized chip
- show increase in specific capture
- quantify changes in EV concentration before and after flowing EVs through device
- analyze PCR results
- run multiple dilutions of target EVs through five microfluidic devices in series
- measure capture efficiency of target EVs on surfaces of microfluidic devices
- analyze enrichment levels of target EV capture
- show highest capture efficiencies in first and second microfluidic devices
- compare efficiency of capturing target EVs using single microfluidic device and dual chip setup
- evaluate capture of two target EVs using dual chip setup
- compare capture efficiencies with respect to different control antibody surface chemistries

### Example 6

- determine target EV capture efficiency
- calculate limit of detection
- identify current limit of detection

### Example 7

- characterize capture and release of target EVs from surfaces of microfluidic devices
- compare EV capture on surface of microfluidic device for different linker molecule sizes
- release captured EVs using proteinase K solution
- release captured EVs using thermally responsive gelatin nanocoating
- quantify captured EVs remaining on surface of microfluidic device after extraction

### Example 8

- compare microfluidic devices to standard EV isolation methods
- evaluate benefit of herringbone pattern grooves
- investigate impact of shear stress on EV capture
- highlight suitability for visualization of EVs by immunoaffinity staining
- describe experimental setup for evaluating microfluidic devices
- present results of experiments

### Example 9

- introduce molecular profiling of tumor-derived EVs from GBM patients
- discuss importance of tumor-derived EVs in GBM diagnosis
- describe experimental setup for testing clinical utility of microfluidic systems
- present results of molecular profiling of tumor-derived EVs
- compare EGFRvIII mRNA levels in serum and plasma-derived EVs
- analyze specificity of microfluidic devices for EGFRvIII mutation
- compare total wild-type EGFR signal levels in patients and controls
- discuss results of comparing microfluidic devices to traditional biopsy methods
- analyze RNA sequencing data for characteristic GBM expression signatures
- present heatmaps of RNA of EVs isolated using microfluidic devices
- discuss unsupervised clustering analysis of RNA sequencing data
- analyze differential expression between EV isolated using ultracentrifugation and microfluidic devices
- present comprehensive characterization of GBM EV RNA
- identify genes associated with patient survival, disease progression, and tumor resistance
- discuss results of unsupervised cluster analysis for gene signatures of EVs isolated from microfluidic device

## OTHER EMBODIMENTS

- disclaim limitation

